Sanara MedTech Statistics Share Statistics Sanara MedTech has 8.89M
shares outstanding. The number of shares has increased by 1.61%
in one year.
Shares Outstanding 8.89M Shares Change (YoY) 1.61% Shares Change (QoQ) -0.16% Owned by Institutions (%) 10.69% Shares Floating 2.96M Failed to Deliver (FTD) Shares 216 FTD / Avg. Volume 0.49%
Short Selling Information The latest short interest is 233.09K, so 2.62% of the outstanding
shares have been sold short.
Short Interest 233.09K Short % of Shares Out 2.62% Short % of Float 5.64% Short Ratio (days to cover) 3.23
Valuation Ratios The PE ratio is -29.15 and the forward
PE ratio is -17.89.
Sanara MedTech's PEG ratio is
-0.24.
PE Ratio -29.15 Forward PE -17.89 PS Ratio 3.25 Forward PS 2 PB Ratio 7.15 P/FCF Ratio -1226.64 PEG Ratio -0.24
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sanara MedTech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.18,
with a Debt / Equity ratio of 0.82.
Current Ratio 2.18 Quick Ratio 2 Debt / Equity 0.82 Debt / EBITDA -17.35 Debt / FCF -140.59 Interest Coverage -2.15
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $614.7K Profits Per Employee $-68.54K Employee Count 141 Asset Turnover 0.98 Inventory Turnover 2.96
Taxes Income Tax 247.35K Effective Tax Rate -2.56%
Stock Price Statistics The stock price has increased by -3.56% in the
last 52 weeks. The beta is 1.26, so Sanara MedTech's
price volatility has been higher than the market average.
Beta 1.26 52-Week Price Change -3.56% 50-Day Moving Average 27.67 200-Day Moving Average 31.93 Relative Strength Index (RSI) 38.06 Average Volume (20 Days) 44,200
Income Statement In the last 12 months, Sanara MedTech had revenue of 86.67M
and earned -9.66M
in profits. Earnings per share was -1.14.
Revenue 86.67M Gross Profit 78.53M Operating Income -6.72M Net Income -9.66M EBITDA -1.86M EBIT -6.78M Earnings Per Share (EPS) -1.14
Full Income Statement Balance Sheet The company has 15.88M in cash and 32.29M in
debt, giving a net cash position of -16.41M.
Cash & Cash Equivalents 15.88M Total Debt 32.29M Net Cash -16.41M Retained Earnings -37.78M Total Assets 96.38M Working Capital 23.56M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.78K
and capital expenditures -205.85K, giving a free cash flow of -229.63K.
Operating Cash Flow -23.78K Capital Expenditures -205.85K Free Cash Flow -229.63K FCF Per Share -0.03
Full Cash Flow Statement Margins Gross margin is 90.61%, with operating and profit margins of -7.75% and -11.15%.
Gross Margin 90.61% Operating Margin -7.75% Pretax Margin -11.15% Profit Margin -11.15% EBITDA Margin -2.15% EBIT Margin -7.75% FCF Margin -0.26%
Dividends & Yields SMTI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for SMTI is $49.5,
which is 84.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $49.5 Price Target Difference 84.4% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 10, 2019. It was a
backward
split with a ratio of 1:100.
Last Split Date May 10, 2019 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 2.65 Piotroski F-Score 4
